Found: 4
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2019
Shuvatova V.G., Semochkina Yu.P., Posypanova G.A., Moskaleva E.Yu.
Introduction. Cancer stem cells (CSCs), which are less sensitive to chemotherapeutic drugs than other tumor cells, play a key role in the initiation and development of the tumor process. Maintenance of CSCs determines the risk of cancer recurrence. The aim of …
Research article2013
Moskaleva E.Yu., Kondrasheva I.G., Popova O.N., Semochkina Yu.P., Shmargun A.M., Severin S.E.
Salinomycin is referred to the group of the polyether antibiotics with ionophore activity. Currently salinomycin is considered as a potential anticancer drug. The aim of this work was to investigate the cytotoxic activity of salinomycin against MDR1+ (Mel-8) a…
Research article2012
Kiselev V.I., Alakhov V.Yu., Semov A.B., Iourtchenko L.V., Liu Lin Fang, Li Shengmin, Xu Yan, Su Xiaoxue, Muyzhnek E.L., Paltsev M.A.
There is a growing body of evidence confirming the validity of the concept of cancer stem cells (CSCs). It is becoming increasingly obvious that CSCs, possessing higher tumorigenicity, metastasis-initiating activity and chemoresistance, are a source of tumor g…
Research article2012
Moskaleva E.Yu., Severin S.E.
In this review the recent data regarding cancer stem cells (CSCs), the mechanisms of their drug resistance and the development of novel anti-CSC therapies are summarized. Recent studies suggest that salinomycin has selective toxicity for CSCs. Salinomycin is a…